Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

BACKGROUND: Despite the overall high degree of response to pharmacotherapy, consensus is lacking on how to judge clinical response or define optimal treatment/remission when treating adults with attention-deficit/hyperactivity disorder (ADHD). This study examined clinical response and symptomatic re...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattingly, Greg W, Weisler, Richard H, Young, Joel, Adeyi, Ben, Dirks, Bryan, Babcock, Thomas, Lasser, Robert, Scheckner, Brian, Goodman, David W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568402/
https://www.ncbi.nlm.nih.gov/pubmed/23356790
http://dx.doi.org/10.1186/1471-244X-13-39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568402/
https://www.ncbi.nlm.nih.gov/pubmed/23356790
http://dx.doi.org/10.1186/1471-244X-13-39

Ejemplares similares